Komori
Daito Pharmaceutical (4577) · PolicyRaisedLatest Earnings (2026-10-14): "Restated"

Balancing growth investment, financial strengthening and stable dividends

First written in FY2016. 15 of 36 entries say "Raised", first in FY2017. Latest entry: 2026-10-14.

36entries
11years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2019-Q3Cited as achievedFY2023-Q3 – FY2024-Q32016: 22017: 420172018: 420182019: 420192020: 420202021: 220212022: 420222023: 320232024: 120242025: 220252026: 62026
Same theme, other companies
Optimally Allocating Resources Among Growth Investment, Strengthening the Financial Base and Shareholder ReturnsA theme 346 companies write about · 2 as a headwind · 356 as a tailwind

63 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.Comparing 200 of the theme's 361 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-14RestatedEarnings

    「2027年５月期(2026年６月１日～2027年５月31日)の通期連結業績予想につきましては、2026年７月10日に公表いたしました予想数値に変更はありません。」

    配当予想は直近公表値から変更されておらず、通期予想を維持している。
  2. FY2026RaisedAnnual report

    「The company has also already decided on a policy of increasing the dividend per share toward the fiscal year ending May 2027. Through continued stable and proactive returns to shareholders, it will work to enhance corporate value and address the issue of a PBR below 1x.」

    In addition to its stable and progressive dividend policies, the company explicitly stated its policy of increasing the dividend per share toward the fiscal year ending May 2027.
  4. FY2026-H1RestatedAnnual report

    「At a meeting of the Board of Directors held on 14 January 2026, the following resolution was passed concerning the interim dividend for the current period.\n(a) Total dividend: ¥591 million\n(b) Dividend per share: ¥20.00」

    The company resolved to pay an interim dividend of ¥20 per share based on the post-June 2025 stock split basis, continuing its track record of stable dividend payments.
  5. FY2025RaisedAnnual report

    「The basic policy is to pay stable dividends to shareholders, taking into account not only the performance for the relevant period but also future growth investment and the strengthening of the financial position. Under the medium-term management plan DTP2027 (fiscal years ending May 2025 through May 2027), the company has adopted a policy of paying progressive dividends.」

    In addition to its existing stable dividend policy, the company explicitly stated its policy of paying progressive dividends during the period covered by DTP2027. The interim dividend was ¥35 per share, up from ¥30 in the previous period.
  6. FY2025-H1RaisedAnnual report

    「At a meeting of the Board of Directors held on 10 January 2025, the following resolution was passed concerning the interim dividend for the current period. (a) Total dividend: ¥536 million (b) Dividend per share: ¥35.00」

    The interim dividend was set at ¥35 per share, an increase of ¥5 from the previous period's interim dividend of ¥30.
  7. FY2024-Q3RestatedAnnual report

    「At a meeting of the Board of Directors held on 12 January 2024, the following resolution was passed concerning the interim dividend for the current period. (a) Total dividend: ¥475 million (b) Dividend per share: ¥30.00 (c) Effective date of the dividend payment claim and payment commencement date: 1 February 2024」

    This records the resolution and payment of an interim dividend of ¥30 per share, maintaining the same level as the previous period's interim dividend.
  8. FY2024-Q1Cited as achievedAnnual report

    「Board meeting held on 14 July 2023 Common shares 432 30 31 May 2023 7 August 2023 Retained earnings」

    This records the resolution and payment on 7 August 2023 of the FY2023 year-end dividend of ¥30 per share.
  9. FY2023-Q3Cited as achievedAnnual report

    「13 January 2023 Board of Directors Common shares 432 30 30 November 2022 1 February 2023 Retained earnings」

    This records the payment on 1 February 2023 of the ¥30-per-share interim dividend.
  10. FY2023-Q2RaisedAnnual report

    「At a meeting of the Board of Directors held on 13 January 2023, the following resolution was passed concerning the interim dividend for the current period. (a) Total dividend: ¥432 million (b) Dividend per share: ¥30.00」

    The interim dividend for the current period was set at ¥30 per share, an increase of ¥5 from the previous period's interim dividend of ¥25.
  11. FY2023-Q1Cited as achievedAnnual report

    「Board meeting held on 14 July 2022 Common shares 500 35 31 May 2022 3 August 2022 Retained earnings」

    This records the payment on 3 August 2022 of the FY2022 year-end dividend of ¥35 per share.
  12. FY2022RaisedAnnual report

    「14 July 2022 Board resolution 500 35.00」

    The year-end dividend was set at ¥35 per share, bringing the annual dividend, including the ¥25 interim dividend, to ¥60. This includes a ¥10 commemorative dividend marking the 80th anniversary of the company's founding, and represents an increase from the previous period's annual dividend of ¥46.
  13. FY2022-Q3Cited as achievedAnnual report

    「14 January 2022 Board of Directors Common shares 345,512 25 30 November 2021 1 February 2022 Retained earnings」

    This records the payment on 1 February 2022 of the ¥25-per-share interim dividend.
  14. FY2022-Q2RaisedAnnual report

    「At a meeting of the Board of Directors held on 14 January 2022, the following resolution was passed concerning the interim dividend for the current period. (a) Total dividend: ¥345.512 million (b) Dividend per share: ¥25.00」

    The interim dividend for the current period was set at ¥25 per share, an increase of ¥2 from the previous period's interim dividend of ¥23.
  15. FY2021-Q3RaisedAnnual report

    「14 January 2021 Board of Directors Common shares 315,412 23 30 November 2020 1 February 2021 Retained earnings」

    The interim dividend for the current period was set at ¥23 per share, an increase of ¥3 from the previous period's interim dividend of ¥20.
  16. FY2021-Q2RaisedAnnual report

    「At a meeting of the Board of Directors held on 14 January 2021, the following resolution was passed concerning the interim dividend for the current period: (a) Total dividends: ¥315.412 million (b) Amount per share: ¥23.00」

    The interim dividend for the current period was approved at ¥23 per share, an increase of ¥3 from the previous period's interim dividend of ¥20.
  17. FY2021-Q1Cited as achievedAnnual report

    「Board of Directors meeting held on 10 July 2020 Common shares 342,368 26 31 May 2020 6 August 2020 Retained earnings」

    The company recorded the approval and payment of a ¥26 per-share dividend as the year-end dividend for the previous fiscal year.
  18. FY2020RaisedAnnual report

    「10 July 2020 342,368 26.00 Board of Directors resolution」

    The year-end dividend was set at ¥26 per share, bringing the annual dividend to ¥46 together with the ¥20 interim dividend. This was an increase from the previous period's annual dividend of ¥38 and includes a ¥6 commemorative dividend marking the 10th anniversary of the company's listing.
  19. FY2020-Q3Cited as achievedAnnual report

    「Board of Directors meeting held on 14 January 2020 Common shares 253,140 20 30 November 2019 3 February 2020 Retained earnings」

    The payment of the ¥20 per-share interim dividend on 3 February 2020 was recorded.
  20. FY2020-Q2RaisedAnnual report

    「At a meeting of the Board of Directors held on 14 January 2020, the following resolution was passed concerning the interim dividend for the current period: (a) Total dividends: ¥253.140 million (b) Amount per share: ¥20.00」

    The interim dividend for the current period was approved at ¥20 per share, an increase of ¥2 from the previous period's interim dividend of ¥18.
  21. FY2020-Q1Cited as achievedAnnual report

    「At a meeting of the Board of Directors held on 12 July 2019, the following resolution was passed concerning the year-end dividend: (a) Total dividends: ¥250.273 million (b) Amount per share: ¥20.00 (c) Effective date of dividend payment claim and payment commencement date: 8 August 2019」

    The company recorded the approval and payment of a ¥20 per-share dividend as the year-end dividend for the previous fiscal year.
  22. FY2019RaisedAnnual report

    「12 July 2019 250,273 20.00 Board of Directors resolution」

    The year-end dividend was set at ¥20 per share, bringing the annual dividend to ¥38 together with the ¥18 interim dividend. This was an increase from the previous period's annual dividend of ¥33.
  23. FY2019-Q3RestatedAnnual report

    「At a meeting of the Board of Directors held on 11 January 2019, the following resolution was passed concerning the interim dividend for the current period: (a) Total dividends: ¥225.247 million (b) Amount per share: ¥18.00」

    The resolution and payment of an interim dividend of ¥18 per share for the current period were recorded, continuing the company's record of stable dividends.
  24. FY2019-Q2RestatedAnnual report

    「At a meeting of the Board of Directors held on 11 January 2019, the following resolution was passed concerning the interim dividend for the current period: (a) Total dividends: ¥225.247 million (b) Amount per share: ¥18.00」

    The resolution to pay an interim dividend of ¥18 per share was recorded, continuing a stable dividend at the same level as the same period of the previous year.
  25. FY2019-Q1RestatedAnnual report

    「Board of Directors meeting held on 13 July 2018 Common shares 225,248 18 31 May 2018 8 August 2018 Retained earnings」

    A year-end dividend of ¥18 per share was paid, maintaining a stable dividend at the same level as the same period of the previous year.
  26. FY2018RestatedAnnual report

    「With respect to returning profits to shareholders, we place importance on paying stable dividends, taking into account not only performance for the period but also future growth investment and efforts to strengthen the financial position.」

    The company continued its policy of stable dividends, taking growth investment and strengthening the financial position into account, and paid an interim dividend of ¥15 and a year-end dividend of ¥18 for the current period.
  27. FY2018-Q3RestatedAnnual report

    「At a meeting of the Board of Directors held on 12 January 2018, the following resolution was passed concerning the interim dividend for the current period: (a) Total dividends: ¥187.709 million (b) Amount per share: ¥15.00 (c) Effective date of dividend payment claim and payment commencement date: 1 February 2018」

    An interim dividend of ¥15 per share was approved and paid, continuing the company's record of stable dividends.
  28. FY2018-Q2RestatedAnnual report

    「At a meeting of the Board of Directors held on 12 January 2018, the following resolution was passed concerning the interim dividend for the current period: (a) Total dividends: ¥187.709 million (b) Amount per share: ¥15.00 (c) Effective date of dividend payment claim and payment commencement date: 1 February 2018」

    The resolution to pay an interim dividend of ¥15 per share was recorded, continuing the company's record of stable dividends.
  29. FY2018-Q1Cited as achievedAnnual report

    「Board of Directors meeting held on 11 July 2017 Common shares 225,254 18 31 May 2017 8 August 2017 Retained earnings」

    A year-end dividend of ¥18 per share was paid on 8 August 2017.
  30. FY2017RaisedAnnual report

    「11 July 2017 Board of Directors resolution 225,254 18.00」

    In addition to the ¥15 interim dividend, the year-end dividend was set at ¥18, bringing the annual dividend per share to ¥33. The year-end dividend includes a ¥3 commemorative dividend marking the company's 75th anniversary.
  31. FY2017-Q3RestatedAnnual report

    「At a meeting of the Board of Directors held on 13 January 2017, the following resolution was passed concerning the interim dividend for the current period: (a) Total dividends: ¥187.715 million (b) Amount per share: ¥15.00」

    An interim dividend of ¥15 per share was approved, continuing the company's record of stable dividends.
  32. FY2017-Q2RestatedAnnual report

    「At a meeting of the Board of Directors held on 13 January 2017, the following resolution was passed concerning the interim dividend for the current period: (a) Total dividends: ¥187.715 million (b) Amount per share: ¥15.00」

    An interim dividend of ¥15 per share was approved, continuing the company's record of stable dividends.
  33. FY2017-Q1RestatedAnnual report

    「At a meeting of the Board of Directors held on 12 July 2016, the following resolution was passed concerning the year-end dividend: (b) Amount per share: ¥15.00」

    A year-end dividend of ¥15 per share, equal to the previous period, was approved, reflecting the company's stable dividend policy.
  34. FY2016First statedAnnual report

    「With respect to returning profits to shareholders, we place importance on paying stable dividends, taking into account not only performance for the period but also future growth investment and efforts to strengthen the financial position.」

    The basic policy is to pay dividends twice a year. For the current period, the interim and year-end dividends are listed as ¥15 per share each.
Moved together

"Expansion and Rationalization of Production and R&D Facilities" moved the same way as this thread, in the same document, in 12 of its 36 moves.

1288766★123456
  1. ★This thread
  2. 1Expansion and Rationalization of Production and R&D Facilities12×
  3. 2Sales Growth of Generic APIs and In-House-Developed Formulations8×
  4. 3Reducing the interest-bearing debt ratio and strengthening equity capital8×
  5. 4Expected Expansion of the Generic Drug Market7×
  6. 5Stable operation of the Chinese drug product manufacturing plant6×
  7. 6Customer Credit Risk6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Daito Pharmaceutical yet. It last moved in the Earnings of 2026-10-14: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Balancing growth investment, financial strengthening and stable dividends | Daito Pharmaceutical Co.,Ltd. (4577) | Komori